Co-Diagnostics, Inc.
CODXNasdaqCIK 1692415HealthcareFiscal year ends Dec 31
Reports and events: 138 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2020-11-0216:45 ET | 8-K | 4.02 Non-reliance on financial statements; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-20-020339 |
| 2020-08-1316:12 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001493152-20-015523 |
| 2020-05-1509:14 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-20-008931 |
| 2020-05-1416:06 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001493152-20-008745 |
| 2020-03-3017:30 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001493152-20-005305 |
| 2020-02-2717:12 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-20-003091 |
| 2020-02-1917:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-20-002743 |
| 2020-02-1117:22 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-20-001966 |
| 2020-01-2709:44 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-20-001137 |
| 2019-11-1216:01 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001493152-19-016885 |
| 2019-09-0514:00 ET | 8-K | 5.07 Shareholder vote results | 0001493152-19-013719 |
| 2019-08-1415:46 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001493152-19-012480 |
| 2019-08-0911:42 ET | DEF 14A | Proxy statementPeriod 2019-08-09 | 0001493152-19-011962 |
| 2019-07-0516:15 ET | 8-K | 3.01 Delisting notice | 0001493152-19-010319 |
| 2019-06-2617:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-19-009755 |
| 2019-05-1417:01 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001493152-19-007113 |
| 2019-04-3015:13 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-19-006157 |
| 2019-04-0118:22 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001493152-19-004300 |
| 2019-02-2514:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-19-002495 |
| 2019-02-0517:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-19-001402 |
| 2019-02-0409:16 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-19-001285 |
| 2019-01-2517:19 ET | 8-K | 8.01 Other events | 0001493152-19-000974 |
| 2019-01-0313:19 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-19-000111 |
| 2018-12-1212:57 ET | DEF 14A | Proxy statementPeriod 2018-12-12 | 0001493152-18-017374 |
| 2018-11-1410:54 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001493152-18-015919 |
| 2018-11-0106:04 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-18-015065 |
| 2018-08-1015:41 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001493152-18-011357 |
| 2018-08-0909:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-18-011230 |
| 2018-05-1417:25 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001493152-18-006835 |
| 2018-03-2811:52 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001477932-18-001468 |
| 2017-11-1417:06 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001477932-17-005611 |
| 2017-08-2517:10 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001477932-17-004217 |
| 2017-07-1306:17 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-17-003272 |
| 2017-07-1017:30 ET | S-1/A | Registration statement, amended | 0001477932-17-003231 |
| 2017-06-2310:17 ET | S-1/A | Registration statement, amended | 0001477932-17-002969 |
| 2017-06-0909:15 ET | S-1/A | Registration statement, amended | 0001477932-17-002732 |
| 2017-05-2417:19 ET | S-1/A | Registration statement, amended | 0001477932-17-002536 |
| 2017-04-2816:14 ET | S-1 | Registration statement | 0001477932-17-002006 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:01 ET. Listed shows no prices and gives no investment advice.